Petrie M Rainey

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi HIV drug interactions: the good, the bad, and the other
    Petrie M Rainey
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195 7110, USA
    Ther Drug Monit 24:26-31. 2002
  2. ncbi The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects
    Petrie M Rainey
    Yale University School of Medicine, New Haven, Conn, USA
    Am J Addict 11:66-74. 2002
  3. ncbi Automatic reporting of estimated glomerular filtration rate--jumping the gun?
    Petrie M Rainey
    Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    Clin Chem 52:2184-7. 2006
  4. ncbi Reducing routine ionized calcium measurement
    Geoffrey S Baird
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195 7110, USA
    Clin Chem 55:533-40. 2009
  5. ncbi A rapid and simple high-performance liquid chromatography assay for the leflunomide metabolite, teriflunomide (A77 1726), in renal transplant recipients
    Kimia Sobhani
    Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195 7110, USA
    Am J Clin Pathol 133:454-7. 2010
  6. ncbi Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, PO Box 980109, Richmond, VA 23298, USA
    Am J Addict 13:163-80. 2004
  7. ncbi Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S224-34. 2006
  8. ncbi Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S235-46. 2006
  9. ncbi Interaction between buprenorphine and atazanavir or atazanavir/ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, VA, USA
    Drug Alcohol Depend 91:269-78. 2007
  10. ncbi The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA
    Clin Infect Dis 37:476-82. 2003

Detail Information

Publications13

  1. ncbi HIV drug interactions: the good, the bad, and the other
    Petrie M Rainey
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195 7110, USA
    Ther Drug Monit 24:26-31. 2002
    ..However, drug measurements before introduction of an interacting drug can establish patient-specific targets that can guide subsequent dosing adjustment...
  2. ncbi The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects
    Petrie M Rainey
    Yale University School of Medicine, New Haven, Conn, USA
    Am J Addict 11:66-74. 2002
    ..3 +/- 61.0 vs. 35.0 +/- 17.5 h) were detected. These results suggest that methadone dose change is not likely to be necessary for patients treated with lamivudine/zidovudine combination pharmacotherapy...
  3. ncbi Automatic reporting of estimated glomerular filtration rate--jumping the gun?
    Petrie M Rainey
    Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    Clin Chem 52:2184-7. 2006
  4. ncbi Reducing routine ionized calcium measurement
    Geoffrey S Baird
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195 7110, USA
    Clin Chem 55:533-40. 2009
    ..Ionized calcium (iCa) is measured frequently in hospitalized patients, and hypocalcemia is frequently found, seemingly supporting the practice...
  5. ncbi A rapid and simple high-performance liquid chromatography assay for the leflunomide metabolite, teriflunomide (A77 1726), in renal transplant recipients
    Kimia Sobhani
    Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195 7110, USA
    Am J Clin Pathol 133:454-7. 2010
    ..Intraday and interday coefficients of variation were 1.5% or less and 5.6% or less, respectively. The method was linear to 200 microg/mL (740 micromol/L), which is well above teriflunomide concentrations that are likely to be observed...
  6. ncbi Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, PO Box 980109, Richmond, VA 23298, USA
    Am J Addict 13:163-80. 2004
    ..While no toxicities were observed, clinicians should be aware of the potential for drug interactions when patients require treatment with nelfinavir and these opiate medications...
  7. ncbi Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S224-34. 2006
    ..Adjustments of doses of either buprenorphine or EFV or DLV are not likely to be necessary when these drugs are administered for the treatment of opiate dependence and HIV disease...
  8. ncbi Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S235-46. 2006
    ..Adjustments of doses of either buprenorphine or NFV, LPV/R, or RTV are not likely to be necessary when these drugs are administered for the treatment of opioid dependence and HIV disease...
  9. ncbi Interaction between buprenorphine and atazanavir or atazanavir/ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, VA, USA
    Drug Alcohol Depend 91:269-78. 2007
    ..Atazanavir or atazanavir/ritonavir may increase buprenorphine and buprenorphine metabolite concentrations and might require a decreased buprenorphine dose...
  10. ncbi The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA
    Clin Infect Dis 37:476-82. 2003
    ..Lopinavir is a potent inducer of methadone metabolism, and treatment with L/R requires clinical monitoring and increased methadone doses in some patients, whereas ritonavir has no significant effect on methadone metabolism...
  11. ncbi Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Am J Addict 15:23-34. 2006
    ....
  12. ncbi The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis
    David C Perlman
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin Infect Dis 41:1638-47. 2005
    ..We examined the pharmacokinetics of rifampin and ethambutol in a cohort of patients with HIV-related TB who were treated in the United States...
  13. ncbi The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis
    David C Perlman
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin Infect Dis 38:556-64. 2004
    ..For therapeutic monitoring of PZA drug exposure, determination of a 2-h postdose concentration appears as reliable as 2- or 3-time point estimates of the AUC for PZA...